Neurenati Therapeutics
Developer of novel regenerative therapies intended for the treatment of Hirschsprung disease. The company focuses on developing innovative therapy via growth factor to treat newborns with Hirschsprung...
Valuation
$6.4M
Latest known
Share Price
N/A
Total Raised
$4.3M
Last Round
N/A